Hequilan, Mercideta C.
HRN: 29-39-91 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/05/2026
METRONIDAZOLE 500MG (TAB)
08/05/2026
08/12/2026
PO
500mg
TID
H.pylori Infection
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: